DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» LNCaP
LNCaP
P53 and PTEN Expression Contribute to the Inhibition of EGFR Downstream Signaling Pathway by Cetuximab
Indirect Antitumor Effects of Bisphosphonates on Prostatic Lncap Cells Co-Cultured with Bone Cells
Prostate Cancer Stromal Cells and Lncap Cells Coordinately Activate
Cell Line Lncap'
On the Biological Properties of Prostate Cancer Cells by Modulation of Inflammatory and Steroidogenesis Pathway Genes
Active Estrogen Synthesis and Its Function in Prostate Cancer-Derived Stromal Cells
Cell Adhesion and Chemotaxis in Prostate Cancer Metastasis to Bone: a Minireview
A Novel Anti-Androgen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth in Vitro and in Vivo
Repression of Cell Proliferation and Androgen Receptor Activity in Prostate Cancer Cells by 2’-Hydroxyflavanone
Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells
Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of B(1,6)-Branched Oligosaccharides As a Marker of Tumor Progression
Androgen Receptor As a Licensing Factor for DNA Replication in Androgen-Sensitive Prostate Cancer Cells
Switch from Antagonist to Agonist of the Androgen Receptor Blocker Bicalutamide Is Associated with Prostate Tumour Progression I
The Anti-Proliferative Effects of Enterolactone in Prostate Cancer Cells: Evidence for the Role of DNA Licencing Genes, Mi-R106b Cluster Expression, and PTEN Dosage
Targeting Cathepsin K Diminishes Prostate Cancer Establishment and Growth in Murine Bone
Enzalutamide, an Androgen Receptor Signaling Inhibitor, Induces Tumor
Identification of Metastasis-Associated Genes in Prostate Cancer by Genetic Profiling of Human Prostate Cancer Cell Lines
Synergistic in Vitro Activity of MOR209/ES414 in Combination
Top View
Key Players in Prostate Cancer Bone Metastasis
The Effects of Selenium on Estrogen-Regulated Gene Expression in Lncap Prostate Cancer Cells
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
Role of SPARC in Bone Remodeling and Cancer‐Related Bone Metastasis
Exosomes from Lncap Cells Promote Osteoblast Activity Through Mir‑375 Transfer
A Secreted Isoform of Erbb3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells
Current Mouse and Cell Models in Prostate Cancer Research
Growth of Human Prostate Cancer Cells Is Significantly Suppressed in Vitro with Sodium Butyrate Through Apoptosis
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
NF-Kb2/P52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
Constitutive Activation of Stat3 in Human Prostate Tumors and Cell Lines: Direct Inhibition of Stat3 Signaling Induces Apoptosis of Prostate Cancer Cells1
SUPPLEMENTAL METHODS Cell Lines and Cell Culture RWPE-1 Cells
A Metastatic and Androgen-Sensitive Human Prostate Cancer Model Using Intraprostatic Inoculation of Lncap Cells in SCID Mice1
Tumour Suppressor PTEN Regulates Cell Cycle and Protein Kinase B/Akt Pathway in Breast Cancer Cells
Estrogen Receptor &Beta
Analyzing the Expression of Biomarkers in Prostate Cancer Cell Lines CHEN-YING SU 1# , GWO-CHE HUANG 2# , YOU-CHENG CHANG 1, YU-JEN CHEN 2 and HSU-WEI FANG 1,3
Increased Cell Growth and Tumorigenicity in Human Prostate Lncap Cells by Overexpression to Cyclin D1
Growth and Characterization of Lncap Prostate Cancer Cell Spheroids 1
Androgen Receptor Degradation by the Proteolysis-Targeting Chimera
Δnp63α Promotes Adhesion of Metastatic Prostate Cancer Cells to the Bone Through Regulation of CD82
In Vitro Human Cell Culture Models for the Study of Prostate Cancer
Characterization of the Androgen Receptor in a Benign Prostate Tissue-Derived Human Prostate Epithelial Cell Line: RC-165N/Human Telomerase Reverse Transcriptase
Is PTEN Loss Associated with Clinical Outcome Measures in Human Prostate Cancer?
Insulin Growth Factor-Binding Protein 2 Is a Candidate Biomarker for PTEN Status and PI3K/Akt Pathway Activation in Glioblastoma and Prostate Cancer
Radiopotentiation of Enzalutamide Over Human Prostate Cancer Cells As Assessed by Real-Time Cell Monitoring
Phenotypic Characterization of Immortalized Normal and Primary Tumor-Derived Human Prostate Epithelial Cell Cultures
Co-Targeting Prostate Cancer Epithelium and Bone Stroma By
Whole-Genome Sequence of the Metastatic PC3 and Lncap Human Prostate Cancer Cell Lines
Differentially Expressed Genes in Two Lncap Prostate Cancer Cell Lines Reflecting Changes During Prostate Cancer Progression Markku H
Osteoblast-Derived Factors Induce an Expression Signature That Identifies Prostate Cancer Metastasis and Hormonal Progression
Osteoprotegerin Inhibits Prostate Cancer–Induced Osteoclastogenesis and Prevents Prostate Tumor Growth in the Bone
Androgen Induces Differentiation of a Human Papillomavirus 16 E6/E7 Immortalized Prostate Epithelial Cell Line
Effect of Selective Estrogen Receptor Modulators on Cell Proliferation and Estrogen Receptor Activities in Normal Human Prostate Stromal and Epithelial Cells
Cell Line Profile - Vcap (ECACC Catalogue No
Cx43 Present at the Leading Edge Membrane Governs Promigratory
Inhibition of Lncap Prostate Cancer Cells by Means of Androgen Receptor Antisense Oligonucleotides
THE HUMAN PROSTATIC CANCER CELL LINE Lncap and ITS DERIVED SUBLINES: an in VITRO MODEL for the STUDY of ANDROGEN SENSITIVITY
Review of Animal Models of Prostate Cancer Bone Metastasis
The Effects of Phytoestrogens on Lncap Prostate Cancer Cells
Androgen Receptors in Prostate Cancer
Histone Deacetylase Inhibitors Selectively Suppress Expression of HDAC7
Resistance to Docetaxel in Prostate Cancer Is Associated with Androgen Receptor Activation and Loss of KDM5D Expression
3D Cell Culture Model for Prostate Cancer Cells to Mimic Inflammatory Microenvironment †
Lncap Culture Conditions +/- Androgen Treatment 1. Source
PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Androgen and Androgen Receptor Antagonist Responsive Primary African-American Benign Prostate Epithelial Cell Line
Lncap Model of Human Prostatic Carcinoma1
Fulvestrant (ICI 182,780) Down-Regulates Androgen Receptor Expression and Diminishes Androgenic Responses in Lncap Human Prostate Cancer Cells
Analysis of Novel Enzalutamide-Resistant Cells: Upregulation of Testis-Specific Y-Encoded Protein Gene Promotes the Expression of Androgen Receptor Splicing Variant 7
Independent Lncap Cells: EGF Versus Androgen Signalling
The Estrogen Receptor Signaling Pathway Activated by Phthalates Is Linked with Transforming Growth Factor-Β in the Progression of Lncap Prostate Cancer Models
Multiple Metastases in a Novel Lncap Model of Human Prostate Cancer
Curcumin Downregulates Cell Survival Mechanisms in Human Prostate Cancer Cell Lines
Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Bone Metastatic Lncap-Derivative C4 -2B Prostate Cancer Cell Line Mineralizes Invitro